RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/18663611http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/18663611http://www.w3.org/2000/01/rdf-schema#comment"Prostate cancer is the most common type of solid tumor and a leading cause of cancer-related death of men living in the developed world. In recent years, the molecular mechanisms involved in prostate cancer development and/or progression have been intensely studied and several genes have been identified. TGIFLX/Y (TGIFLX and TGIFLY) are members of the homeobox superfamily of genes whose function(s) is unknown. To investigate TGIFLX/Y mRNA expression in prostate cancer, we studied two different types of clinical samples, namely 60 prostate tumors and 15 cases of benign prostate hyperplasia (BPH), by RT-PCR. Our results revealed that most prostate tumors (73.5%) express at least one of these genes, although different patterns of TGIFLX/Y mRNA expression were observed. In some tumor samples the expression of both genes was detected, while in others no expression of either gene was observed. Notably, there was a significant correlation between expression of both TGIFLX and TGIFLY and a Gleason score of >or=6 (P = 0.038). By contrast, expression of TGIFLX/Y mRNA in BPH samples could not be detected. These results suggest an association of TGIFLX/Y expression with the progression of prostate cancer."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.org/dc/terms/identifier"doi:10.1007/s12032-008-9086-7"xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/author"Heidari M."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/author"Greene W.K."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/author"Raoofian R."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/author"Ayati M."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/author"Modarresi M.H."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/author"Ousati Ashtiani Z."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/author"Sabah Goulian B."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/name"Med Oncol"xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/pages"73-77"xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/title"Association of TGIFLX/Y mRNA expression with prostate cancer."xsd:string
http://purl.uniprot.org/citations/18663611http://purl.uniprot.org/core/volume"26"xsd:string
http://purl.uniprot.org/citations/18663611http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/18663611
http://purl.uniprot.org/citations/18663611http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/18663611
http://purl.uniprot.org/uniprot/#_Q3ZCM9-mappedCitation-18663611http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18663611
http://purl.uniprot.org/uniprot/#_Q8IUE0-mappedCitation-18663611http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18663611
http://purl.uniprot.org/uniprot/#_Q8IUE1-mappedCitation-18663611http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18663611
http://purl.uniprot.org/uniprot/Q8IUE0http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18663611
http://purl.uniprot.org/uniprot/Q3ZCM9http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18663611
http://purl.uniprot.org/uniprot/Q8IUE1http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18663611